nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0429	0.101	CbGeAlD
Trimipramine—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0288	0.0657	CcSEcCtD
Trimipramine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0277	0.0654	CbGeAlD
Trimipramine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0225	0.0532	CbGeAlD
Trimipramine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0197	0.0449	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0422	CcSEcCtD
Trimipramine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0386	CcSEcCtD
Trimipramine—HTR3A—nerve—amyotrophic lateral sclerosis	0.0142	0.0335	CbGeAlD
Trimipramine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0323	CcSEcCtD
Trimipramine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.0118	0.0279	CbGeAlD
Trimipramine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0258	CcSEcCtD
Trimipramine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0112	0.0264	CbGeAlD
Trimipramine—HTR2A—pons—amyotrophic lateral sclerosis	0.011	0.0261	CbGeAlD
Trimipramine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0249	CcSEcCtD
Trimipramine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0239	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.01	0.0229	CcSEcCtD
Trimipramine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00987	0.0225	CcSEcCtD
Trimipramine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0219	CcSEcCtD
Trimipramine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00953	0.0225	CbGeAlD
Trimipramine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0095	0.0217	CcSEcCtD
Trimipramine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00942	0.0223	CbGeAlD
Trimipramine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00884	0.0209	CbGeAlD
Trimipramine—DRD2—nerve—amyotrophic lateral sclerosis	0.00868	0.0205	CbGeAlD
Trimipramine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00864	0.0204	CbGeAlD
Trimipramine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00829	0.0189	CcSEcCtD
Trimipramine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.0081	0.0192	CbGeAlD
Trimipramine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00808	0.0191	CbGeAlD
Trimipramine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00807	0.0184	CcSEcCtD
Trimipramine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00804	0.0184	CcSEcCtD
Trimipramine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0181	CcSEcCtD
Trimipramine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00768	0.0175	CcSEcCtD
Trimipramine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0174	CcSEcCtD
Trimipramine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0174	CcSEcCtD
Trimipramine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0173	CcSEcCtD
Trimipramine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0173	CcSEcCtD
Trimipramine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00734	0.0174	CbGeAlD
Trimipramine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0166	CcSEcCtD
Trimipramine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.0072	0.017	CbGeAlD
Trimipramine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0159	CcSEcCtD
Trimipramine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0159	CcSEcCtD
Trimipramine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00663	0.0157	CbGeAlD
Trimipramine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.0065	0.0154	CbGeAlD
Trimipramine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0142	CcSEcCtD
Trimipramine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00618	0.0141	CcSEcCtD
Trimipramine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00609	0.0144	CbGeAlD
Trimipramine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00596	0.0136	CcSEcCtD
Trimipramine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00573	0.0135	CbGeAlD
Trimipramine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0057	0.013	CcSEcCtD
Trimipramine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0129	CcSEcCtD
Trimipramine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00559	0.0128	CcSEcCtD
Trimipramine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0125	CcSEcCtD
Trimipramine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00538	0.0123	CcSEcCtD
Trimipramine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00527	0.012	CcSEcCtD
Trimipramine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00525	0.012	CcSEcCtD
Trimipramine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0118	CcSEcCtD
Trimipramine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0117	CcSEcCtD
Trimipramine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00507	0.012	CbGeAlD
Trimipramine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0116	CcSEcCtD
Trimipramine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0114	CcSEcCtD
Trimipramine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00497	0.0113	CcSEcCtD
Trimipramine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00495	0.0117	CbGeAlD
Trimipramine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.0049	0.0116	CbGeAlD
Trimipramine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0111	CcSEcCtD
Trimipramine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0111	CcSEcCtD
Trimipramine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00473	0.0108	CcSEcCtD
Trimipramine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00465	0.011	CbGeAlD
Trimipramine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0106	CcSEcCtD
Trimipramine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00449	0.0102	CcSEcCtD
Trimipramine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0102	CcSEcCtD
Trimipramine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0101	CcSEcCtD
Trimipramine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00998	CcSEcCtD
Trimipramine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00985	CcSEcCtD
Trimipramine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00429	0.0101	CbGeAlD
Trimipramine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00977	CcSEcCtD
Trimipramine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00969	CcSEcCtD
Trimipramine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00412	0.00975	CbGeAlD
Trimipramine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00934	CcSEcCtD
Trimipramine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00409	0.00967	CbGeAlD
Trimipramine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00395	0.009	CcSEcCtD
Trimipramine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00896	CcSEcCtD
Trimipramine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00896	CcSEcCtD
Trimipramine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00391	0.00923	CbGeAlD
Trimipramine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0038	0.00899	CbGeAlD
Trimipramine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00373	0.00881	CbGeAlD
Trimipramine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00813	CcSEcCtD
Trimipramine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00355	0.00838	CbGeAlD
Trimipramine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00802	CcSEcCtD
Trimipramine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00342	0.00808	CbGeAlD
Trimipramine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00341	0.00807	CbGeAlD
Trimipramine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00775	CcSEcCtD
Trimipramine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00749	CcSEcCtD
Trimipramine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00319	0.00754	CbGeAlD
Trimipramine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00721	CcSEcCtD
Trimipramine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00315	0.00745	CbGeAlD
Trimipramine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00715	CcSEcCtD
Trimipramine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00714	CcSEcCtD
Trimipramine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0071	CcSEcCtD
Trimipramine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00307	0.00726	CbGeAlD
Trimipramine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00305	0.0072	CbGeAlD
Trimipramine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00673	CcSEcCtD
Trimipramine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00289	0.00683	CbGeAlD
Trimipramine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00285	0.00674	CbGeAlD
Trimipramine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00271	0.0064	CbGeAlD
Trimipramine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00268	0.00634	CbGeAlD
Trimipramine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00266	0.00628	CbGeAlD
Trimipramine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00259	0.00613	CbGeAlD
Trimipramine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00257	0.00607	CbGeAlD
Trimipramine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00256	0.00606	CbGeAlD
Trimipramine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00256	0.00604	CbGeAlD
Trimipramine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.0025	0.00591	CbGeAlD
Trimipramine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.0025	0.0059	CbGeAlD
Trimipramine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00247	0.00584	CbGeAlD
Trimipramine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00246	0.00581	CbGeAlD
Trimipramine—HTR3A—brain—amyotrophic lateral sclerosis	0.00244	0.00577	CbGeAlD
Trimipramine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00243	0.00575	CbGeAlD
Trimipramine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00234	0.00554	CbGeAlD
Trimipramine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00224	0.00529	CbGeAlD
Trimipramine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00216	0.00511	CbGeAlD
Trimipramine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00214	0.00506	CbGeAlD
Trimipramine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00208	0.00492	CbGeAlD
Trimipramine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00206	0.00488	CbGeAlD
Trimipramine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00203	0.00481	CbGeAlD
Trimipramine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00203	0.0048	CbGeAlD
Trimipramine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00202	0.00476	CbGeAlD
Trimipramine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00199	0.00471	CbGeAlD
Trimipramine—HTR1D—brain—amyotrophic lateral sclerosis	0.00198	0.00468	CbGeAlD
Trimipramine—HTR2C—brain—amyotrophic lateral sclerosis	0.00196	0.00464	CbGeAlD
Trimipramine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00195	0.00461	CbGeAlD
Trimipramine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00192	0.00453	CbGeAlD
Trimipramine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00188	0.00444	CbGeAlD
Trimipramine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00187	0.00443	CbGeAlD
Trimipramine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00186	0.0044	CbGeAlD
Trimipramine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00184	0.00434	CbGeAlD
Trimipramine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.0018	0.00425	CbGeAlD
Trimipramine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00176	0.00415	CbGeAlD
Trimipramine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00171	0.00405	CbGeAlD
Trimipramine—HTR1A—brain—amyotrophic lateral sclerosis	0.00165	0.0039	CbGeAlD
Trimipramine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00164	0.00387	CbGeAlD
Trimipramine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00154	0.00364	CbGeAlD
Trimipramine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00153	0.00361	CbGeAlD
Trimipramine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00152	0.0036	CbGeAlD
Trimipramine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00151	0.00358	CbGeAlD
Trimipramine—DRD2—brain—amyotrophic lateral sclerosis	0.00149	0.00353	CbGeAlD
Trimipramine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00148	0.00351	CbGeAlD
Trimipramine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00345	CbGeAlD
Trimipramine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00143	0.00337	CbGeAlD
Trimipramine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00129	0.00304	CbGeAlD
Trimipramine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00293	CbGeAlD
Trimipramine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00121	0.00286	CbGeAlD
Trimipramine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00119	0.00282	CbGeAlD
Trimipramine—HRH1—brain—amyotrophic lateral sclerosis	0.00118	0.00279	CbGeAlD
Trimipramine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00117	0.00277	CbGeAlD
Trimipramine—ADRA2A—brain—amyotrophic lateral sclerosis	0.00116	0.00274	CbGeAlD
Trimipramine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00271	CbGeAlD
Trimipramine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00113	0.00267	CbGeAlD
Trimipramine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00112	0.00265	CbGeAlD
Trimipramine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.0011	0.00261	CbGeAlD
Trimipramine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.001	0.00237	CbGeAlD
Trimipramine—HTR2A—brain—amyotrophic lateral sclerosis	0.000984	0.00233	CbGeAlD
Trimipramine—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.000919	0.591	CrCbGaD
Trimipramine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000897	0.00212	CbGeAlD
Trimipramine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000844	0.00199	CbGeAlD
Trimipramine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000812	0.00192	CbGeAlD
Trimipramine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000794	0.00188	CbGeAlD
Trimipramine—ABCB1—brain—amyotrophic lateral sclerosis	0.000645	0.00152	CbGeAlD
Trimipramine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000635	0.409	CrCbGaD
Trimipramine—HTR1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.84e-05	0.000572	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.83e-05	0.000571	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.79e-05	0.000569	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.7e-05	0.000562	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.68e-05	0.000561	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	7.66e-05	0.000559	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.6e-05	0.000554	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.54e-05	0.00055	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.53e-05	0.000549	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.45e-05	0.000544	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.44e-05	0.000543	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.42e-05	0.000541	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.37e-05	0.000538	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.3e-05	0.000533	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.28e-05	0.000531	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.27e-05	0.00053	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.23e-05	0.000527	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.19e-05	0.000524	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.19e-05	0.000524	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.15e-05	0.000521	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.15e-05	0.000521	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.12e-05	0.000519	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	7.09e-05	0.000517	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.07e-05	0.000516	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.06e-05	0.000515	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.01e-05	0.000511	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.99e-05	0.00051	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.93e-05	0.000505	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.93e-05	0.000505	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.92e-05	0.000505	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.92e-05	0.000505	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.84e-05	0.000499	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	6.75e-05	0.000493	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.64e-05	0.000485	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.62e-05	0.000483	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.49e-05	0.000474	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6.45e-05	0.000471	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.43e-05	0.000469	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.38e-05	0.000465	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.34e-05	0.000462	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	6.31e-05	0.000461	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.31e-05	0.00046	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.28e-05	0.000458	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.26e-05	0.000457	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.22e-05	0.000454	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.21e-05	0.000453	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.21e-05	0.000453	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.19e-05	0.000452	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.16e-05	0.00045	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.15e-05	0.000448	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.08e-05	0.000443	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.06e-05	0.000442	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.01e-05	0.000438	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.98e-05	0.000436	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.91e-05	0.000431	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.89e-05	0.00043	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.85e-05	0.000427	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	5.83e-05	0.000425	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.82e-05	0.000424	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.81e-05	0.000424	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.76e-05	0.00042	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.72e-05	0.000417	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.71e-05	0.000417	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	5.69e-05	0.000415	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.65e-05	0.000412	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	5.59e-05	0.000408	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.57e-05	0.000406	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.54e-05	0.000404	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.51e-05	0.000402	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.5e-05	0.000401	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	5.36e-05	0.000391	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.31e-05	0.000388	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.31e-05	0.000387	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.31e-05	0.000387	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.28e-05	0.000385	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.27e-05	0.000385	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.19e-05	0.000379	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.18e-05	0.000378	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.13e-05	0.000374	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.11e-05	0.000373	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.08e-05	0.000371	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.06e-05	0.000369	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.06e-05	0.000369	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.05e-05	0.000368	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.04e-05	0.000368	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.01e-05	0.000365	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.95e-05	0.000361	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.94e-05	0.00036	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.91e-05	0.000358	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.84e-05	0.000353	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.82e-05	0.000351	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.8e-05	0.00035	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	4.78e-05	0.000349	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.76e-05	0.000347	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.72e-05	0.000344	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.7e-05	0.000343	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.67e-05	0.000341	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.66e-05	0.00034	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.63e-05	0.000338	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.61e-05	0.000336	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.6e-05	0.000335	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.59e-05	0.000335	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.58e-05	0.000334	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.57e-05	0.000333	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.49e-05	0.000328	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.41e-05	0.000322	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.41e-05	0.000322	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.4e-05	0.000321	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.39e-05	0.00032	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.37e-05	0.000319	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.36e-05	0.000318	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.33e-05	0.000316	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.27e-05	0.000311	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.26e-05	0.00031	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.2e-05	0.000307	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.2e-05	0.000306	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.18e-05	0.000305	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.17e-05	0.000304	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.16e-05	0.000304	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.07e-05	0.000297	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4e-05	0.000292	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.99e-05	0.000291	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.98e-05	0.00029	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.92e-05	0.000286	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.91e-05	0.000286	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.91e-05	0.000285	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.88e-05	0.000283	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.87e-05	0.000282	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.81e-05	0.000278	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.8e-05	0.000277	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.8e-05	0.000277	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.77e-05	0.000275	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.76e-05	0.000274	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.73e-05	0.000272	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.68e-05	0.000268	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.65e-05	0.000267	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.64e-05	0.000265	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	3.64e-05	0.000265	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.63e-05	0.000265	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.59e-05	0.000262	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.55e-05	0.000259	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.53e-05	0.000258	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.5e-05	0.000256	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.47e-05	0.000253	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.38e-05	0.000247	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.34e-05	0.000243	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.31e-05	0.000242	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.26e-05	0.000238	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.25e-05	0.000237	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.25e-05	0.000237	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.23e-05	0.000236	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.19e-05	0.000233	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.14e-05	0.000229	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.12e-05	0.000228	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.12e-05	0.000227	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.07e-05	0.000224	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.06e-05	0.000223	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.02e-05	0.000221	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3e-05	0.000219	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.99e-05	0.000218	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.99e-05	0.000218	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.97e-05	0.000216	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.92e-05	0.000213	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.9e-05	0.000212	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.88e-05	0.00021	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.79e-05	0.000203	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.78e-05	0.000203	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.76e-05	0.000201	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.75e-05	0.000201	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.74e-05	0.0002	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.73e-05	0.000199	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.71e-05	0.000198	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.7e-05	0.000197	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.65e-05	0.000194	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.57e-05	0.000188	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.56e-05	0.000187	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.52e-05	0.000184	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.52e-05	0.000184	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.51e-05	0.000183	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.5e-05	0.000182	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.49e-05	0.000182	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.47e-05	0.00018	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.47e-05	0.00018	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.41e-05	0.000176	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.4e-05	0.000175	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-05	0.000173	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.36e-05	0.000172	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.35e-05	0.000172	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.34e-05	0.000171	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.31e-05	0.000168	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.3e-05	0.000168	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.29e-05	0.000167	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.17e-05	0.000159	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.15e-05	0.000157	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.12e-05	0.000155	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.11e-05	0.000154	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.08e-05	0.000152	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.08e-05	0.000152	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.04e-05	0.000149	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.94e-05	0.000142	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.92e-05	0.00014	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.9e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.9e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.88e-05	0.000137	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.86e-05	0.000135	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.85e-05	0.000135	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.82e-05	0.000133	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	0.00013	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000129	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.77e-05	0.000129	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.76e-05	0.000128	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.75e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.67e-05	0.000122	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.63e-05	0.000119	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.63e-05	0.000119	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.6e-05	0.000117	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.6e-05	0.000117	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.6e-05	0.000116	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.58e-05	0.000115	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.57e-05	0.000115	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.57e-05	0.000114	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.000113	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.54e-05	0.000112	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.52e-05	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.51e-05	0.00011	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.5e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.48e-05	0.000108	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.46e-05	0.000106	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-05	0.000104	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.38e-05	0.000101	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.38e-05	0.000101	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.36e-05	9.93e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.36e-05	9.91e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.33e-05	9.72e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	9.72e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.3e-05	9.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.24e-05	9.04e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.23e-05	9e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-05	8.94e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.21e-05	8.86e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.19e-05	8.69e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.18e-05	8.64e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	8.53e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.13e-05	8.27e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.05e-05	7.63e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.03e-05	7.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.03e-05	7.49e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.01e-05	7.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.36e-06	6.83e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.01e-06	5.84e-05	CbGpPWpGaD
